Share
Print

Stanford University

Total Awards:

81

ICOC Committed funds:

259 597 522

Major Facility Name:

Lorry I. Lokey Stem Cell Research Building

Awards to the Institution

			Funding
Basic Biology III:	Joanna Wysocka	Enhancer-mediated gene regulation during early human embryonic development	$1,425,600
Basic Biology III:	Sean Wu	Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells	$1,425,600
Basic Biology III:	Renee Reijo Pera	Correlated time-lapse imaging and single cell molecular analysis of human embryo development	$1,425,600
Basic Biology III:	Michael Clarke	USP16 controls stem cell number: implications for Down Syndrome	$1,425,600
New Faculty II:	Ching-Pin Chang	VEGF signaling in adventitial stem cells in vascular physiology and disease	$3,330,931
New Cell Lines:	Renee Reijo Pera	Derivation and comparative analysis of human pluripotent ESCs, iPSCs and SSCs: Convergence to an embryonic phenotype	$1,410,042
New Cell Lines:	Julie Baker	Derivation of hESC Lines with Disease Lesions	$1,424,412
New Cell Lines:	Michele Calos	Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses	$1,406,875
New Cell Lines:	Michael Longaker	Derivation and analysis of pluripotent stem cell lines with inherited TGF-b mediated disorders from donated IVF embryos and reprogrammed adult skin fibroblasts	$1,424,412
Tools and Technologies II:	Brian Rutt	Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters	$1,930,608
Tools and Technologies II:	Irving Weissman	Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs	$1,869,487
Tools and Technologies II:	Sarah Heilshorn	Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels	$1,415,981
Tools and Technologies II:	Ricardo Dolmetsch	Development of small molecule screens for autism using patient-derived iPS cells	$1,884,808
Tools and Technologies II:	Marius Wernig	Cellular tools to study brain diseases affecting synaptic transmission	$1,906,494
Tools and Technologies II:	Michele Calos	Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation	$1,619,627
Early Translational II:	Michele Calos	Stem Cell Therapy for Duchenne Muscular Dystrophy	$2,325,933
Basic Biology II:	Steven Artandi	Self-renewal and senescence in iPS cells derived from patients with a stem cell disease	$1,430,908
Basic Biology II:	Garry Nolan	Kinase signaling analysis of iPS cell reprogramming and differentiation	$1,447,956
Basic Biology II:	Aaron Hsueh	Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation	$1,432,197
Disease Team Research I:	Alfred Lane	iPS Cell-Based Treatment of Dominant Dystrophic Epidermolysis Bullosa	$11,709,574
Disease Team Research I:	Gary Steinberg	Embryonic-Derived Neural Stem Cells for Treatment of Motor Sequelae following Sub-cortical Stroke	$20,000,000
Disease Team Research I:	Irving Weissman	Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells	$19,999,996
Basic Biology I:	Susan McConnell	Identification and characterization of human ES-derived DA neuronal subtypes	$1,407,076
Basic Biology I:	Julien Sage	The retinoblastoma (RB) gene family in cellular reprogramming	$1,436,185
Basic Biology I:	Helen Blau	Molecular Mechanisms of Reprogramming towards Pluripotency	$1,414,841
Research Training II:	Renee Reijo Pera	CIRM Training Program	$7,974,291
Tools and Technologies I:	Helen Blau	Regulation of Stem Cell Fate in Bioengineered Arrays of Hydrogel Microwells	$949,608
New Faculty I:	Karl Deisseroth	Bioengineering technology for fast optical control of differentiation and function in stem cells and stem cell progeny	$3,154,719
New Faculty I:	Anne Brunet	Molecular mechanisms involved in adult neural stem cell maintenance	$2,348,520
New Faculty I:	Howard Chang	Noncoding RNAs in Cell Fate Determination	$3,203,926
			Total: $105,561,807.00

Pages

© 2013 California Institute for Regenerative Medicine